DWA
SRDX

Dorsey Wright & Associates’s Surmodics SRDX Stock Holding History

Dorsey Wright & Associates’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-168
Closed -$7K – 333
2019
Q1 		$7K Sell
168
-168
-50% -$8.56K ﹤0.01% 269
2018
Q4 		$16K Buy
336
+56
+20% +$3.36K ﹤0.01% 175
2018
Q3 		$21K Buy
+280
New +$19.3K ﹤0.01% 156

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dorsey Wright & Associates's SRDX Position: Q2 2019 in Review

Dorsey Wright & Associates sold out of Surmodics (SRDX) in Q2 2019, closing a stake of 168 shares — an estimated $7K sold.

Dorsey Wright & Associates first reported a position in SRDX in Q3 2018 and held it in 3 quarters. The position peaked at $21K in Q3 2018. 140 funds tracked by Wall St. Rank hold SRDX as of Q2 2019.

  • Dorsey Wright & Associates reported no remaining Surmodics position as of Q2 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 168 Surmodics shares in Q2 2019, an estimated $7K.
  • Dorsey Wright & Associates first reported a position in Surmodics in Q3 2018 and held it in 3 quarters.
  • Dorsey Wright & Associates's Surmodics position peaked at $21K in Q3 2018.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q2 2019.

Based on Dorsey Wright & Associates's 13F filing for Q2 2019, filed 2 Jul 2019.